Related Experiment Videos
Remarks at the human genome announcement
1Celera Genomics, Rockville, MD 20850, USA.
Functional & Integrative Genomics
|January 22, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Characterization of brain D(2) dopamine receptors.
Neurochemistry international·2010
Individual genomes instead of race for personalized medicine.
Clinical pharmacology and therapeutics·2008
Sequencing the genome of Plasmodium falciparum.
Current opinion in infectious diseases·2006
The malaria genome sequencing project.
Expert reviews in molecular medicine·2003
Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.
Journal of bacteriology·2002
Microbial disease in humans: A genomic perspective.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology·2002
Dual-reference projection defines a callable core and reference-sensitive shell in a Qiantang River Megalobrama draft assembly.
Functional & integrative genomics·2026
Single-cell immune landscape of patients with different ovarian reserves during COH.
Functional & integrative genomics·2026
Exposure-informed lung transcriptomic analysis links predicted NNK targets to cell type-specific remodeling programs in idiopathic pulmonary fibrosis.
Functional & integrative genomics·2026
Identification of the BCO gene family and its effect on body coloration in Lutjanus erythropterus.
Functional & integrative genomics·2026
LGMN regulates endothelial-to-mesenchymal transition via the p38 MAPK pathway to promote pulmonary fibrosis.
Functional & integrative genomics·2026
Dihydrolipoamide dehydrogenase promotes hepatocellular carcinoma progression and modulates cuproptosis-dependent cell death.
Functional & integrative genomics·2026
Optical genome mapping enhanced by refined variant interpretation in pediatric acute lymphoblastic leukemia.
The Journal of pathology·2026
Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice.
npj metabolic health and disease·2026